693
Views
15
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy

, , , , , , , , , , , , , , , , , & show all
Pages 1335-1341 | Received 22 May 2015, Accepted 14 Sep 2015, Published online: 22 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Katsuhiro Miura, Noriyoshi Iriyama, Yoshihiro Hatta & Masami Takei. (2021) Personalized patient care with aggressive hematological malignancies in non-responders to first-line treatment. Expert Review of Precision Medicine and Drug Development 6:3, pages 203-215.
Read now
Hiromichi Takahashi, Katsuhiro Miura, Masaru Nakagawa, Masahiko Sugitani, Yusuke Amano, Daisuke Kurita, Masashi Sakagami, Shimon Ohtake, Yoshihito Uchino, Hitomi Kodaira, Noriyoshi Iriyama, Sumiko Kobayashi, Atsuko Hojo, Yujin Kobayashi, Yukio Hirabayashi, Machiko Kusuda, Yoshihiro Hatta, Tomohiro Nakayama & Masami Takei. (2016) Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy. Leukemia & Lymphoma 57:12, pages 2784-2790.
Read now

Articles from other publishers (13)

Tatjana Terzic, Vladimir Otasevic, Vojin Vukovic, Sofija Sarac, Kristina Tomic, Biljana Mihaljevic & Darko Antic. (2022) “Double expressor” diffuse large B-cell lymphoma: A case report and literature review. Medicinski pregled Medical review 75:Suppl. 1, pages 106-110.
Crossref
Michael Y. He & Robert Kridel. (2021) Treatment resistance in diffuse large B-cell lymphoma. Leukemia 35:8, pages 2151-2165.
Crossref
Jisun Hwang, Chong Suh, Kyung Kim, Ho Kim, Austin Kim, Jeffrey Craig, Ke Chen, Joel Roberson, Jeffrey Guenette & Raymond Huang. (2021) The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. Cancers 13:13, pages 3369.
Crossref
Carla Isabelly Rodrigues-Fernandes, Arnaldo Gonçalves Junior, Ciro Dantas Soares, Thayná Melo de Lima Morais, Gleyson Kleber do Amaral-Silva, Maria Goretti Freire de Carvalho, Lucas Lacerda de Souza, Fábio Ramôa Pires, Teresa Cristina Ribeiro Bartholomeu dos Santos, Débora Lima Pereira, Luis Fernando Rivero, Kelly Tambasco Bezerra, Bruno Augusto Benevenuto de Andrade, Mário José Romañach, Michele Agostini, Javier Rendón Henao, Amanda de Farias Gabriel, Décio dos Santos Pinto Júnior, Manoela Domingues Martins, Mateus José de Carvalho Pereira, Ricardo Alves Mesquita, Ricardo Santiago Gomez, Giovanna Ribeiro Souto, Alan Roger Santos-Silva, Pablo Agustin Vargas, Márcio Ajudarte Lopes, Oslei Paes de Almeida, Flávia Sirotheau Corrêa Pontes, Hélder Antônio Rebelo Pontes, Rommel Mario Rodríguez Burbano & Felipe Paiva Fonseca. (2021) Oral and oropharyngeal diffuse large B-cell lymphoma and high-grade B-cell lymphoma: A clinicopathologic and prognostic study of 69 cases. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 131:4, pages 452-462.e4.
Crossref
Denisse Castro, Brady Beltrán, María del Pilar Quiñones, Carlos Pachas, Yesenia Huerta, Karen Lalupu, Ronald Mendoza & Jorge J. Castillo. (2021) Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma. Leukemia Research 102, pages 106513.
Crossref
Madeleine R. Berendsen, Wendy B. C. Stevens, Michiel van den Brand, J. Han van Krieken & Blanca Scheijen. (2020) Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance. Cancers 12:12, pages 3553.
Crossref
Anuvrat Sircar, Sayan Chowdhury, Amber Hart, William Bell, Satishkumar Singh, Lalit Sehgal & Narendranath Epperla. (2020) Impact and Intricacies of Bone Marrow Microenvironment in B-cell Lymphomas: From Biology to Therapy. International Journal of Molecular Sciences 21:3, pages 904.
Crossref
Yang Liu & Stefan Klaus Barta. (2019) Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. American Journal of Hematology 94:5, pages 604-616.
Crossref
Joshua Allen, Ana Lucia Ruano Mendez, Lisa Rybicki, Yazeed Sawalha  , Deepa Jagadeesh, Robert Dean, Brad Pohlman, Mitchell R. Smith, Eric D. Hsi & Brian T. Hill. (2018) Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant. Therapeutic Advances in Hematology 9:4, pages 81-87.
Crossref
Alex F. Herrera, Scott J. Rodig, Joo Y. Song, Young Kim, Gabriel K. Griffin, Dongyun Yang, Liana Nikolaenko, Matthew Mei, Victoria Bedell, Paola Dal Cin, Christine Pak, Edwin P. Alyea, Lihua E. Budde, Robert Chen, Yi-Bin Chen, Wing C. Chan, Corey S. Cutler, Vincent T. Ho, John Koreth, Amrita Krishnan, Joyce L. Murata-Collins, Sarah Nikiforow, Joycelynne Palmer, German A. Pihan, Raju Pillai, Leslie Popplewell, Steven T. Rosen, Tanya Siddiqi, Aliyah R. Sohani, Jasmine Zain, Larry W. Kwak, Dennis D. Weisenburger, David M. Weinstock, Robert J. Soiffer, Joseph H. Antin, Stephen J. Forman, Auayporn P. Nademanee & Philippe Armand. (2018) Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma. Biology of Blood and Marrow Transplantation 24:3, pages 514-520.
Crossref
J. Han van Krieken. (2016) New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015. Journal of Hematopathology 9:1, pages 19-27.
Crossref
Eisei Kondo. (2016) Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma. Journal of Clinical and Experimental Hematopathology 56:2, pages 100-108.
Crossref
Kirandeep Kaur, Simar Singh, Helma Zecena, Laurent Dejean & Fabian V. Filipp. (2018) Increased Glutaminolytic Flux and Activation of Mitochondrial Metabolism by BCL2 Hyperactivity in Lymphoma. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.